E&E1d
How ‘green’ inhalers could evade Biden’s drug pricing legacy
AstraZeneca and GlaxoSmithKline produce some of the most widely used inhalers in the United States, including Symbicort and ...
FiercePharma5d
AstraZeneca heads to regulators after Airsupra asthma trial stops early thanks to 'overwhelming efficacy'
In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...
Hosted on MSN6mon
Experts say Medicaid rebate change is behind inhaler price cuts
The rebate change took effect in January. GlaxoSmithKline in January reduced the list price for its Advair Diskus and Advair HFA inhalers, while AstraZeneca also reduced the list price of Symbicort.
Hosted on MSN6mon
AstraZeneca Expands Savings Program for Respiratory Medicines, Aiming to Ease Patient Costs
The updated savings scheme will encompass several key products in AstraZeneca’s US inhaled respiratory medicines lineup, including AIRSUPRA®, BEVESPI AEROSPHERE®, BREZTRI AEROSPHERE®, and SYMBICORT®.
pharmaphorum5d
AZ, Avillion's Airsupra aces asthma rescue therapy trial
The phase 3b BATURA study showed Airsupra (albuterol/budesonide) achieved a statistically significant reduction in the risk of severe asthma exacerbations when used as needed for rescue therapy ...